Cargando…
Predictors of long‐term outcome in heart failure with preserved ejection fraction: a follow‐up from the KaRen study
AIMS: Heart failure (HF) with preserved ejection fraction (HFpEF) has poor long‐term prognosis. We assessed rates and predictors of outcome 10 years after an acute episode of HF. METHODS AND RESULTS: The Karolinska‐Rennes (KaRen) study enrolled HFpEF patients with acute HF, ejection fraction ≥ 45%,...
Autores principales: | Shahim, Angiza, Hourqueig, Marion, Donal, Erwan, Oger, Emmanuel, Venkateshvaran, Ashwin, Daubert, Jean‐Claude, Savarese, Gianluigi, Linde, Cecilia, Lund, Lars H., Hage, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497206/ https://www.ncbi.nlm.nih.gov/pubmed/34374216 http://dx.doi.org/10.1002/ehf2.13533 |
Ejemplares similares
-
Long‐term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non‐cardiac mortality
por: Shahim, Angiza, et al.
Publicado: (2023) -
Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study
por: Hage, Camilla, et al.
Publicado: (2015) -
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
por: Lund, Lars H., et al.
Publicado: (2021) -
Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
por: Löfström, Ulrika, et al.
Publicado: (2019) -
Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction
por: Hage, Camilla, et al.
Publicado: (2020)